Mechanisms of Ageing and Development · Nov 19, 2026
The SET Domain-Containing Methyltransferase Family: From Histone/Non-histone Modifications to Aging-Related Diseases
By Rui LM, Chen JJ, Yang YF et al.
SET domain-containing lysine methyltransferases (KMTs) are critical enzymes that mediate the methylation of both histone and non-histone substrates. Emerging evidence has intricately linked them to aging-related mechanisms and diseases. At the molecular level, KMTs regulate the expression of aging-related genes by establishing activating or repressive histone marks. Furthermore, specific family members contribute to aging regulation by maintaining heterochromatin stability or by modifying non-histone substrates, with the same KMT often exerting opposing, tissue-specific functions across different organs. Importantly, during tumor progression, KMTs can act as tumor suppressors by triggering oncogene-induced senescence; conversely, they can also be co-opted by malignant cells to evade senescence and acquire chemoresistance. This article presents the first systematic review of the functional similarities and differences among most members of the SET-domain-containing family (with brief mention of the PRDM family), with respect to their roles in aging mechanisms. In doing so, it provides a theoretical foundation for a deeper understanding of the epigenetic regulatory networks underlying aging, and offers a basis for the development of anti-aging and anti-tumor therapeutic strategies targeting these KMTs.